Table of Contents: Preface
Chapter 1 pp. 1-26. "Loss of the Future": Prospection Impairments in the Dementias
(Muireann Irish, School of Psychology, the University of New South Wales, Australia, and others)
Chapter 2 pp. 27-58. Memory Binding in Alzheimer’s Disease
(Mario Alfredo Parra, Psychology, Heriot-Watt University, UK, and others)
Chapter 3 pp. 59-98. Alzheimer’s Disease Therapy Targeting BACE1 and Neprilysin
(Masuo Ohno, Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York, USA, and others)
Chapter 4 pp. 99-114. Advances in Tau Immunotherapy
(Julia Gerson and Rakez Kayed, Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, USA, and others)
Chapter 5 pp. 115-128. The 5-Lipoxygenase as a Therapeutic Target for Tauopathy
(Domenico Praticò, Department of Pharmacology, Center for Translational Medicine, Temple University, Philadelphia, PA, USA)
Chapter 6 pp. 129-168. Frontotemporal Dementia and Potential Therapeutics
(Fiona Kumfor, Sandra Baez and Agustin Ibanez, Neuroscience Research Australia, Barker Street, Randwick, Sydney, Australia, and others)
Chapter 7 pp. 169-194. Neurodegeneration and Memory Loss in Down Syndrome: Perspectives on Potential Therapeutics
(Aurélie Ledreux, Eric Hamlett, Jason Lockrow, Krishna Bharani, and Ann-Charlotte Granholm, Department of Neuroscience and the Center on Aging, Medical University of South Carolina, Charleston, SC, USA, and others)
Chapter 8 pp. 195-234. Cognitive Rehabilitation in Multiple Sclerosis
(Joshua Sandry, Nadine Akbar, Mark Zuppichini, and John DeLuca, Psychology Department, Montclair State University, Montclair, NJ, USA, and others)
Contributors
Index |